Pan Tumor Rollover Study

Study Number

615220

Phase

Age Group

Adult

Principal Investigator

Purpose

Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types.

Check your eligibility for this trial

Check now

Full Title

Pan Tumor Study for Long Term Treatment of Cancer Patients Who Have Participated in BMS Sponsored Trials Investigating Nivolumab and Other Cancer Therapies

ClinicalTrials.Gov ID

NCT03899155

Get more information and eligibility criteria for this trial at ClinicalTrials.gov

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.